Recombinant multi-species EPGN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EPGN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the epidermal growth factor family. Members of this family are ligands for the epidermal growth factor receptor and play a role in cell survival, proliferation and migration. This protein has been reported to have high mitogenic activity but low affinity for its receptor. Expression of this transcript and protein have been reported in cancer specimens of the breast, bladder, and prostate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
The Alternative Names of target: 2310069M11Rik,ALGV3072,EPG,EPGN,Epgn,Epigen,Epithelial mitogen (EPG),PRO9904,RGD1560084,epigen

Target products collectionGo to EPGN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0181-Ag-1/ GM-Tg-hg-SE0181-Ag-2 Human EPGN protein Human
GM-Tg-rg-SE0181-Ag-1/ GM-Tg-rg-SE0181-Ag-2 Rat EPGN protein Rat
GM-Tg-mg-SE0181-Ag-1/ GM-Tg-mg-SE0181-Ag-2 Mouse EPGN protein Mouse
GM-Tg-cynog-SE0181-Ag-1/ GM-Tg-cynog-SE0181-Ag-2 Cynomolgus/Rhesus macaque EPGN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0181-Ag-1/ GM-Tg-felg-SE0181-Ag-2 Feline EPGN protein Feline
GM-Tg-cang-SE0181-Ag-1/ GM-Tg-cang-SE0181-Ag-2 Canine EPGN protein Canine
GM-Tg-bovg-SE0181-Ag-1/ GM-Tg-bovg-SE0181-Ag-2 Bovine EPGN protein Bovine
GM-Tg-equg-SE0181-Ag-1/ GM-Tg-equg-SE0181-Ag-2 Equine EPGN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0181-Ag-1/ GM-Tg-hg-SE0181-Ag-2; GM-Tg-rg-SE0181-Ag-1/ GM-Tg-rg-SE0181-Ag-2;
GM-Tg-mg-SE0181-Ag-1/ GM-Tg-mg-SE0181-Ag-2; GM-Tg-cynog-SE0181-Ag-1/ GM-Tg-cynog-SE0181-Ag-2;
GM-Tg-felg-SE0181-Ag-1/ GM-Tg-felg-SE0181-Ag-2; GM-Tg-cang-SE0181-Ag-1/ GM-Tg-cang-SE0181-Ag-2;
GM-Tg-bovg-SE0181-Ag-1/ GM-Tg-bovg-SE0181-Ag-2; GM-Tg-equg-SE0181-Ag-1/ GM-Tg-equg-SE0181-Ag-2
Products Name EPGN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name EPGN
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EPGN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.